BFS
NPSP

Bradley Foster & Sargent’s NPS PHARMACEUTICALS INC NPSP Stock Holding History

Bradley Foster & Sargent’s Portfolio NPSP Stock Details NPSP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q4 		– Sell
-6,400
Closed -$204K – 357
2013
Q3 		$204K Buy
+6,400
New +$147K 0.01% 324

Other funds holding NPSP

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
CWAM
Columbia Wanger Asset Management Chicago, Illinois $6.69B AUM 31.14% 1-Year Est. Return
ORI
Oak Ridge Investments Chicago, Illinois $1.77B AUM 63.16% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Bradley Foster & Sargent's NPSP Position: Q4 2013 in Review

Bradley Foster & Sargent sold out of NPS PHARMACEUTICALS INC (NPSP) in Q4 2013, closing a stake of 6,400 shares — an estimated $204K sold.

Bradley Foster & Sargent first reported a position in NPSP in Q3 2013 and held it in 1 quarter. The position peaked at $204K in Q3 2013. 191 funds tracked by Wall St. Rank hold NPSP as of Q4 2013.

  • Bradley Foster & Sargent reported no remaining NPS PHARMACEUTICALS INC position as of Q4 2013 after selling out during the quarter.
  • Bradley Foster & Sargent sold 6,400 NPS PHARMACEUTICALS INC shares in Q4 2013, an estimated $204K.
  • Bradley Foster & Sargent first reported a position in NPS PHARMACEUTICALS INC in Q3 2013 and held it in 1 quarter.
  • Bradley Foster & Sargent's NPS PHARMACEUTICALS INC position peaked at $204K in Q3 2013.
  • 191 funds tracked by Wall St. Rank held NPS PHARMACEUTICALS INC as of Q4 2013.

Based on Bradley Foster & Sargent's 13F filing for Q4 2013, filed 14 Feb 2014.